The groundbreaking treatment of the medication represents a significant breakthrough in the care of the condition. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide909216.blog-eye.com/42357797/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment